{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T09:40:21Z","timestamp":1731490821068,"version":"3.28.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T00:00:00Z","timestamp":1728345600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T00:00:00Z","timestamp":1728345600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1007\/s00520-024-08926-0","type":"journal-article","created":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T11:02:13Z","timestamp":1728385333000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical effect of prophylactic pegfilgrastim in patients with newly diagnosed acute lymphoblastic leukemia who receive intensive chemotherapy"],"prefix":"10.1007","volume":"32","author":[{"given":"Yunji","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youngeun","family":"Jang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung Min","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hee Jeong","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joon Ho","family":"Moon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang Kyun","family":"Sohn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji Yeon","family":"Ham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soon Hee","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong Won","family":"Baek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,10,8]]},"reference":[{"issue":"10230","key":"8926_CR1","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/S0140-6736(19)33018-1","volume":"395","author":"F Malard","year":"2020","unstructured":"Malard F, Mohty M (2020) Acute lymphoblastic leukaemia. Lancet 395(10230):1146\u20131162","journal-title":"Lancet"},{"issue":"15","key":"8926_CR2","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1056\/NEJMra023001","volume":"350","author":"CH Pui","year":"2004","unstructured":"Pui CH, Relling MV, Downing JR (2004) Acute lymphoblastic leukemia. N Engl J Med 350(15):1535\u20131548","journal-title":"N Engl J Med"},{"issue":"6","key":"8926_CR3","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1200\/JCO.1994.12.6.1312","volume":"12","author":"A Preti","year":"1994","unstructured":"Preti A, Kantarjian HM (1994) Management of adult acute lymphoblastic leukemia: present issues and key challenges. J Clin Oncol 12(6):1312\u20131322","journal-title":"J Clin Oncol"},{"issue":"3","key":"8926_CR4","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1200\/JCO.2000.18.3.547","volume":"18","author":"HM Kantarjian","year":"2000","unstructured":"Kantarjian HM, O\u2019Brien S, Smith TL et al (2000) Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia. J Clin Oncol 18(3):547\u2013561","journal-title":"J Clin Oncol"},{"issue":"6","key":"8926_CR5","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1016\/S0889-8588(05)70182-9","volume":"14","author":"HM Kantarjian","year":"2000","unstructured":"Kantarjian HM, Garcia-Manero G (2000) The hyper-CVAD regimen in adult acute lymphocytic leukemia. Hematol Oncol Clin North Am 14(6):1381\u20131396","journal-title":"Hematol Oncol Clin North Am"},{"issue":"17","key":"8926_CR6","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1056\/NEJMe2027937","volume":"383","author":"D Hoelzer","year":"2020","unstructured":"Hoelzer D (2020) Chemotherapy-free treatment - a new era in acute lymphoblastic leukemia? N Engl J Med 383(17):1673\u20131674","journal-title":"N Engl J Med"},{"issue":"suppl 5","key":"8926_CR7","doi-asserted-by":"publisher","first-page":"v111","DOI":"10.1093\/annonc\/mdw325","volume":"27","author":"J Klastersky","year":"2016","unstructured":"Klastersky J, de Naurois J, Rolston K et al (2016) Management of febrile neutropaenia: ESMO clinical practice guidelines. Ann Oncol 27(suppl 5):v111\u2013v118","journal-title":"Ann Oncol"},{"key":"8926_CR8","unstructured":"NCCN clinical practice guidelines in oncology. Hematopoietic growth factors. NCCN. 2024;version 3"},{"issue":"5","key":"8926_CR9","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1177\/1078155215625459","volume":"22","author":"S Mitchell","year":"2016","unstructured":"Mitchell S, Li X, Woods M et al (2016) Comparative effectiveness of granulocyte colony-stimulating factors to prevent febrile neutropenia and related complications in cancer patients in clinical practice: a systematic review. J Oncol Pharm Pract 22(5):702\u2013716","journal-title":"J Oncol Pharm Pract"},{"issue":"4","key":"8926_CR10","first-page":"337","volume":"14","author":"VA Morrison","year":"2007","unstructured":"Morrison VA, Wong M, Hershman D et al (2007) Observational study of the prevalence of febrile neutropenia in patients who received filgrastim or pegfilgrastim associated with 3\u20134 week chemotherapy regimens in community oncology practices. J Manag Care Pharm 14(4):337\u2013348","journal-title":"J Manag Care Pharm"},{"issue":"9","key":"8926_CR11","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1080\/10428190600632832","volume":"47","author":"SW Lane","year":"2006","unstructured":"Lane SW, Crawford J, Kenealy M et al (2006) Safety and efficacy of pegfilgrastim compared to granulocyte colony stimulating factor (G-CSF) supporting a dose-intensive, rapidly cycling anti-metabolite containing chemotherapy regimen (Hyper-CVAD) for lymphoid malignancy. Leuk Lymphoma 47(9):1813\u20131817","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"8926_CR12","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1182\/blood-2015-03-636548","volume":"126","author":"DY Kim","year":"2015","unstructured":"Kim DY, Joo YD, Lim SN et al (2015) Nilotinib combined with multiagent chemotherapy for newly diagnosed Philadelphia-positive acute lymphoblastic leukemia. Blood 126(6):746\u2013756","journal-title":"Blood"},{"issue":"5","key":"8926_CR13","doi-asserted-by":"publisher","first-page":"734","DOI":"10.3904\/kjim.2022.401","volume":"38","author":"DW Baek","year":"2023","unstructured":"Baek DW, Park HS, Sohn SK et al (2023) Rituximab plus multiagent chemotherapy for newly diagnosed CD20-positive acute lymphoblastic leukemia: a prospective phase II study. Korean J Intern Med 38(5):734\u2013746","journal-title":"Korean J Intern Med"},{"issue":"6","key":"8926_CR14","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.3904\/kjim.2021.028","volume":"36","author":"DW Baek","year":"2021","unstructured":"Baek DW, Kim DY, Sohn SK et al (2021) Pediatric-inspired regimen with late intensification and increased dose of L-asparaginase for adult acute lymphoblastic leukemia: the KALLA 1406\/1407 study. Korean J Intern Med 36(6):1471\u20131485","journal-title":"Korean J Intern Med"},{"issue":"1","key":"8926_CR15","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ejca.2010.10.013","volume":"47","author":"MS Aapro","year":"2011","unstructured":"Aapro MS, Bohlius J, Cameron DA et al (2011) 2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours. Eur J Cancer 47(1):8\u201332","journal-title":"Eur J Cancer"},{"issue":"4","key":"8926_CR16","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1038\/s41409-020-01101-z","volume":"56","author":"C Greil","year":"2021","unstructured":"Greil C, Engelhardt M, Ihorst G et al (2021) Prognostic factors for survival after allogeneic transplantation in acute lymphoblastic leukemia. Bone Marrow Transplant 56(4):841\u2013852","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"8926_CR17","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1038\/s41409-022-01691-w","volume":"57","author":"JA Snowden","year":"2022","unstructured":"Snowden JA, S\u00e1nchez-Ortega I, Corbacioglu S et al (2022) Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022. Bone Marrow Transplant 57(8):1217\u20131239","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"8926_CR18","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3904\/kjim.2023.407","volume":"39","author":"JH Yoon","year":"2024","unstructured":"Yoon JH, Lee S (2024) Diagnostic and therapeutic advances in adults with acute lymphoblastic leukemia in the era of gene analysis and targeted immunotherapy. Korean J Intern Med 39(1):34\u201356","journal-title":"Korean J Intern Med"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-024-08926-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-024-08926-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-024-08926-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T09:08:09Z","timestamp":1731488889000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-024-08926-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,8]]},"references-count":18,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["8926"],"URL":"https:\/\/doi.org\/10.1007\/s00520-024-08926-0","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"type":"print","value":"0941-4355"},{"type":"electronic","value":"1433-7339"}],"subject":[],"published":{"date-parts":[[2024,10,8]]},"assertion":[{"value":"3 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures in this study that involved human participants were performed in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"715"}}